Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Merck & Co., Inc.
Report date December 31, 2011 · Filed January 04, 2012
Section 16 reporting ended · disclosed 2012-01-04. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 70,990 |
Reported balance
After 2011-12-31 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2011-12-31 · Tax withholding · Disposed 8,969 · Balance 70,990 F1: Withheld shares related to the 12/31/11 vesting of stock units previously granted to the reporting person on March 30, 2009. F2: Holdings include dividends earned since November 3, 2009. |
| Common Stock - 401(k) PlanSEC Table I · non-derivative | IndirectBy 401(k) | 4,638.645 |
Reported balance
Holding disclosure · report date 2011-12-31 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 4,638.645 F3: Includes shares acquired and dividends earned through December 31, 2011 in the Schering-Plough Employees' Savings Plan, a 401(k) Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: Withheld shares related to the 12/31/11 vesting of stock units previously granted to the reporting person on March 30, 2009.
F2: Holdings include dividends earned since November 3, 2009.
F3: Includes shares acquired and dividends earned through December 31, 2011 in the Schering-Plough Employees' Savings Plan, a 401(k) Plan.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 03, 2009 Filed Nov 9, 2009 17:36 UTC | Merck & Co., Inc. MRK · Entity 2807 | Disposition to issuerStock Option (right to buy) · Derivative | 6,139 | $0.00 Strike: $18.20 | $0.00 |
DisclosureSEC source: 0001225208-09-021935 · doc4.xml · derivative · entry 10 KOHAN RAUL E · CIK 0001238302 · Exe V-P & Pres, Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,861 Underlying: Common Stock · 6,139 shares Expires 2014-02-22 F13 · derivative.exercise_price: The option price for the grant expiring 2/22/14 will convert from $18.20 to $19.95. F7 · price: Pursuant to the Merger Agreement, upon the closing of the Transactions, the option was converted into an option to purchase common shares of New Merck in accordance with the exchange ratio set forth in the Merger Agreement, including an adjustment to the number of shares underlying the option and the option's exercise price. F6 · derivative.exercise_date: The option vested and became exercisable on varying dates pursuant to the terms of the plans under which they were granted. Certain options vested in connection with the closing of the Transactions. Following the Transactions, options continue pursuant to the same terms as were applicable prior to the Transactions. Read SEC document |
| November 03, 2009 Filed Nov 9, 2009 17:36 UTC | Merck & Co., Inc. MRK · Entity 2807 | Disposition to issuerStock Option (right to buy) · Derivative | 5,184 | $0.00 Strike: $17.85 | $0.00 |
DisclosureSEC source: 0001225208-09-021935 · doc4.xml · derivative · entry 9 KOHAN RAUL E · CIK 0001238302 · Exe V-P & Pres, Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,916 Underlying: Common Stock · 5,184 shares Expires 2013-02-23 F12 · derivative.exercise_price: The option price for the grant expiring 2/23/13 will convert from $17.85 to $19.57. F7 · price: Pursuant to the Merger Agreement, upon the closing of the Transactions, the option was converted into an option to purchase common shares of New Merck in accordance with the exchange ratio set forth in the Merger Agreement, including an adjustment to the number of shares underlying the option and the option's exercise price. F6 · derivative.exercise_date: The option vested and became exercisable on varying dates pursuant to the terms of the plans under which they were granted. Certain options vested in connection with the closing of the Transactions. Following the Transactions, options continue pursuant to the same terms as were applicable prior to the Transactions. Read SEC document |
| November 03, 2009 Filed Nov 9, 2009 17:36 UTC | Merck & Co., Inc. MRK · Entity 2807 | Disposition to issuerStock Option (right to buy) · Derivative | 3,026 | $0.00 Strike: $34.68 | $0.00 |
DisclosureSEC source: 0001225208-09-021935 · doc4.xml · derivative · entry 8 KOHAN RAUL E · CIK 0001238302 · Exe V-P & Pres, Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,474 Underlying: Common Stock · 3,026 shares Expires 2012-02-24 F11 · derivative.exercise_price: The option price for the grant expiring 2/24/12 will convert from $34.68 to $38.01. F7 · price: Pursuant to the Merger Agreement, upon the closing of the Transactions, the option was converted into an option to purchase common shares of New Merck in accordance with the exchange ratio set forth in the Merger Agreement, including an adjustment to the number of shares underlying the option and the option's exercise price. F6 · derivative.exercise_date: The option vested and became exercisable on varying dates pursuant to the terms of the plans under which they were granted. Certain options vested in connection with the closing of the Transactions. Following the Transactions, options continue pursuant to the same terms as were applicable prior to the Transactions. Read SEC document |
| November 03, 2009 Filed Nov 9, 2009 17:36 UTC | Merck & Co., Inc. MRK · Entity 2807 | Disposition to issuerStock Option (right to buy) · Derivative | 3,026 | $0.00 Strike: $40.05 | $0.00 |
DisclosureSEC source: 0001225208-09-021935 · doc4.xml · derivative · entry 7 KOHAN RAUL E · CIK 0001238302 · Exe V-P & Pres, Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,474 Underlying: Common Stock · 3,026 shares Expires 2011-02-25 F10 · derivative.exercise_price: The option price for the grant expiring 2/25/11 will convert from $40.05 to $43.90. F7 · price: Pursuant to the Merger Agreement, upon the closing of the Transactions, the option was converted into an option to purchase common shares of New Merck in accordance with the exchange ratio set forth in the Merger Agreement, including an adjustment to the number of shares underlying the option and the option's exercise price. F6 · derivative.exercise_date: The option vested and became exercisable on varying dates pursuant to the terms of the plans under which they were granted. Certain options vested in connection with the closing of the Transactions. Following the Transactions, options continue pursuant to the same terms as were applicable prior to the Transactions. Read SEC document |
| November 03, 2009 Filed Nov 9, 2009 17:36 UTC | Merck & Co., Inc. MRK · Entity 2807 | Disposition to issuerStock Option (right to buy) · Derivative | 10,086 | $0.00 Strike: $45.04 | $0.00 |
DisclosureSEC source: 0001225208-09-021935 · doc4.xml · derivative · entry 6 KOHAN RAUL E · CIK 0001238302 · Exe V-P & Pres, Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,914 Underlying: Common Stock · 10,086 shares Expires 2010-09-24 F9 · derivative.exercise_price: The option price for the grant expiring 9/24/10 will convert from $45.04 to $49.37. F7 · price: Pursuant to the Merger Agreement, upon the closing of the Transactions, the option was converted into an option to purchase common shares of New Merck in accordance with the exchange ratio set forth in the Merger Agreement, including an adjustment to the number of shares underlying the option and the option's exercise price. F6 · derivative.exercise_date: The option vested and became exercisable on varying dates pursuant to the terms of the plans under which they were granted. Certain options vested in connection with the closing of the Transactions. Following the Transactions, options continue pursuant to the same terms as were applicable prior to the Transactions. Read SEC document |
| November 03, 2009 Filed Nov 9, 2009 17:36 UTC | Merck & Co., Inc. MRK · Entity 2807 | Disposition to issuerStock Option (right to buy) · Derivative | 1,983 | $0.00 Strike: $37.75 | $0.00 |
DisclosureSEC source: 0001225208-09-021935 · doc4.xml · derivative · entry 5 KOHAN RAUL E · CIK 0001238302 · Exe V-P & Pres, Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,617 Underlying: Common Stock · 1,983 shares Expires 2010-02-21 F8 · derivative.exercise_price: The option price for the grant expiring 2/21/10 will convert from $37.75 to $41.38. F7 · price: Pursuant to the Merger Agreement, upon the closing of the Transactions, the option was converted into an option to purchase common shares of New Merck in accordance with the exchange ratio set forth in the Merger Agreement, including an adjustment to the number of shares underlying the option and the option's exercise price. F6 · derivative.exercise_date: The option vested and became exercisable on varying dates pursuant to the terms of the plans under which they were granted. Certain options vested in connection with the closing of the Transactions. Following the Transactions, options continue pursuant to the same terms as were applicable prior to the Transactions. Read SEC document |
| November 03, 2009 Filed Nov 9, 2009 17:36 UTC | Merck & Co., Inc. MRK · Entity 2807 | Disposition to issuerStock Option (right to buy) · Derivative | 8,770 | $0.00 Strike: $47.88 | $0.00 |
DisclosureSEC source: 0001225208-09-021935 · doc4.xml · derivative · entry 4 KOHAN RAUL E · CIK 0001238302 · Exe V-P & Pres, Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,230 Underlying: Common Stock · 8,770 shares Expires 2009-12-05 F5 · derivative.exercise_price: The option price for the grant expiring 12/05/09 will convert from $47.875 to $52.48. F7 · price: Pursuant to the Merger Agreement, upon the closing of the Transactions, the option was converted into an option to purchase common shares of New Merck in accordance with the exchange ratio set forth in the Merger Agreement, including an adjustment to the number of shares underlying the option and the option's exercise price. F6 · derivative.exercise_date: The option vested and became exercisable on varying dates pursuant to the terms of the plans under which they were granted. Certain options vested in connection with the closing of the Transactions. Following the Transactions, options continue pursuant to the same terms as were applicable prior to the Transactions. Read SEC document |
| November 03, 2009 Filed Nov 9, 2009 17:36 UTC | Merck & Co., Inc. MRK · Entity 2807 | Disposition to issuerPhantom Stock · Derivative | 28,172 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-09-021935 · doc4.xml · derivative · entry 3 KOHAN RAUL E · CIK 0001238302 · Exe V-P & Pres, Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,380 Underlying: Common Stock · 28,172 shares Expires not disclosed F3 · derivative.exercise_price: Each unit was the economic equivalent of one share of Schering-Plough Corporation common stock. F4 · price: In connection with the Transactions, each share held in the Schering-Plough Corporation stock fund prior to the Transactions of Schering-Plough Corporation's Savings Advantage Plan was converted into 0.5767 shares of New Merck common stock and $10.50 in cash. The plan continues following the Transactions and both the shares and cash will remain in the plan until such time as a disposition is made to the reporting person under the terms of the plan. F4 · derivative.exercise_date: In connection with the Transactions, each share held in the Schering-Plough Corporation stock fund prior to the Transactions of Schering-Plough Corporation's Savings Advantage Plan was converted into 0.5767 shares of New Merck common stock and $10.50 in cash. The plan continues following the Transactions and both the shares and cash will remain in the plan until such time as a disposition is made to the reporting person under the terms of the plan. F4 · derivative.expiration_date: In connection with the Transactions, each share held in the Schering-Plough Corporation stock fund prior to the Transactions of Schering-Plough Corporation's Savings Advantage Plan was converted into 0.5767 shares of New Merck common stock and $10.50 in cash. The plan continues following the Transactions and both the shares and cash will remain in the plan until such time as a disposition is made to the reporting person under the terms of the plan. Read SEC document |
| November 03, 2009 Filed Nov 9, 2009 17:36 UTC | Merck & Co., Inc. MRK · Entity 2807 | Disposition to issuerCommon Stock - 401(k) Plan | 2,420 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-09-021935 · doc4.xml · nonDerivative · entry 2 KOHAN RAUL E · CIK 0001238302 · Exe V-P & Pres, Animal Health 10b5-1 filing: Not disclosed Ownership: Indirect · By 401(k) Disclosed balance after: 3,298 F2 · price: In connection with the Transactions, each share held in the Schering-Plough Corporation stock fund prior to the Transactions of Schering-Plough Corporation's 401(k) plan was converted into 0.5767 shares of New Merck common stock and $10.50 in cash. The plan continues following the Transactions and both the shares and cash will remain in the plan until such time as a disposition is made to the reporting person under the terms of the plan. Read SEC document |
| November 03, 2009 Filed Nov 9, 2009 17:36 UTC | Merck & Co., Inc. MRK · Entity 2807 | Disposition to issuerCommon Stock | 24,424 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-09-021935 · doc4.xml · nonDerivative · entry 1 KOHAN RAUL E · CIK 0001238302 · Exe V-P & Pres, Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,274 F1 · price: Pursuant to the Agreement and Plan of Merger ("Merger Agreement") by and among, inter alia, Merck & Co., Inc., formerly Schering-Plough Corporation, ("New Merck") and Merck Sharp & Dohme Corp., formerly Merck & Co., Inc., and upon the completion of the transactions contemplated therein (the "Transactions"), each common share of Schering-Plough Corporation common stock was converted into 0.5767 shares of New Merck common stock and $10.50 in cash. Any fractional share holdings were paid in cash pursuant to a formula in the Merger Agreement. Read SEC document |
| November 03, 2009 Filed Jan 29, 2010 21:52 UTC Amendment | Merck & Co., Inc. (MRK) · Entity 2807 | GrantCommon Stock | 17,557 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-10-005617 · doc4a.xml · nonDerivative · entry 2 KOHAN RAUL E · CIK 0001238302 · ExecVP&PresAnimalHlth 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,358 F3 · shares: Pursuant to the terms of the Issuer's 2006 Stock Incentive Plan, the shares will become payable on December 31, 2011 provided that the reporting person remains continuously employed by the Issuer through that date, or, if sooner, upon the reporting person's involuntary termination of employment other than for cause. F2 · balance_after: Reflects beneficial ownership as of November 3, 2009. Read SEC document |
| November 03, 2009 Filed Jan 29, 2010 21:52 UTC Amendment | Merck & Co., Inc. (MRK) · Entity 2807 | GrantCommon Stock | 15,527 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-10-005617 · doc4a.xml · nonDerivative · entry 1 KOHAN RAUL E · CIK 0001238302 · ExecVP&PresAnimalHlth 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,801 F1 · shares: Distribution of net after-tax shares of common stock from performance-based share units granted on February 26, 2007. Pursuant to the terms of the Issuer's 2006 Stock Incentive Plan, the shares vested upon the completion of the transactions contemplated by the Agreement and Plan of Merger by and among, inter alia, Merck Sharp & Dohme Corp. (formerly Merck & Co., Inc.) and Merck & Co., Inc. (formerly Schering-Plough Corporation)(the "Transaction"). F2 · balance_after: Reflects beneficial ownership as of November 3, 2009. Read SEC document |
| May 01, 2009 Filed May 5, 2009 18:07 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantOption (right to buy) · Derivative | 59,200 | Not disclosed Strike: $22.91 | Not disclosed |
DisclosureSEC source: 0000310158-09-000052 · koh730.xml · derivative · entry 1 KOHAN RAUL E · CIK 0001238302 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,200 Underlying: Common Shares · 59,200 shares Expires 2016-04-30 F2 · price: Not Applicable. F1 · derivative.exercise_date: Granted under the Schering-Plough Corporation 2006 Stock Incentive Plan and exercisable in one-third increments on May 1 of 2010, 2011 and 2012. The vesting of 11,840 option shares is subject to Schering-Plough's satisfaction of certain performance criteria for the 2009 year. Read SEC document |
| April 01, 2009 Filed Apr 3, 2009 18:44 UTC | Merck & Co., Inc. SGP · Entity 2807 | Exercise / conversionDeferred Stock Unit Award · Derivative | 17,500 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0000310158-09-000020 · koh721.xml · derivative · entry 4 KOHAN RAUL E · CIK 0001238302 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 17,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Not Applicable. F6 · price: Not Applicable. F4 · derivative.exercise_date: Not Applicable. F5 · derivative.expiration_date: Not Applicable. Read SEC document |
| April 01, 2009 Filed Apr 3, 2009 18:44 UTC | Merck & Co., Inc. SGP · Entity 2807 | Tax withholdingCommon Shares | 8,112 | $23.70 | $192,254.40 |
DisclosureSEC source: 0000310158-09-000020 · koh721.xml · nonDerivative · entry 2 KOHAN RAUL E · CIK 0001238302 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,698.91 Read SEC document |
| April 01, 2009 Filed Apr 3, 2009 18:44 UTC | Merck & Co., Inc. SGP · Entity 2807 | Exercise / conversionCommon Shares | 17,500 | $0.00 | $0.00 |
DisclosureSEC source: 0000310158-09-000020 · koh721.xml · nonDerivative · entry 1 KOHAN RAUL E · CIK 0001238302 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,810.91 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Not Applicable. Read SEC document |
| February 27, 2009 Filed Mar 3, 2009 23:52 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantPhantom Stock Unit · Derivative | 66,163 | $17.39 | $1,150,574.57 |
DisclosureSEC source: 0000310158-09-000014 · koh709.xml · derivative · entry 1 KOHAN RAUL E · CIK 0001238302 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,163 Underlying: Common Shares · 66,163 shares Expires not disclosed F1 · derivative.exercise_price: Each unit of phantom stock is the economic equivalent of one share of common stock. The units of phantom stock will be held in the Issuer's Phantom Stock Fund under the Issuer's non-qualified deferred compensation plan, and will become payable, in cash, following the reporting person's termination of service. F1 · derivative.exercise_date: Each unit of phantom stock is the economic equivalent of one share of common stock. The units of phantom stock will be held in the Issuer's Phantom Stock Fund under the Issuer's non-qualified deferred compensation plan, and will become payable, in cash, following the reporting person's termination of service. F1 · derivative.expiration_date: Each unit of phantom stock is the economic equivalent of one share of common stock. The units of phantom stock will be held in the Issuer's Phantom Stock Fund under the Issuer's non-qualified deferred compensation plan, and will become payable, in cash, following the reporting person's termination of service. Read SEC document |
| May 01, 2008 Filed May 5, 2008 20:58 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantOption (right to buy) · Derivative | 57,000 | Not disclosed Strike: $18.85 | Not disclosed |
DisclosureSEC source: 0000310158-08-000038 · koh665.xml · derivative · entry 1 KOHAN RAUL E · CIK 0001238302 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,000 Underlying: Common Shares · 57,000 shares Expires 2015-04-30 F2 · price: Not Applicable. F1 · derivative.exercise_date: Granted under the Schering-Plough Corporation 2006 Stock Incentive Plan and exercisable in one-third increments on May 1 of 2009, 2010 and 2011. The vesting of 11,400 option shares is subject to Schering-Plough's satisfaction of certain performance criteria for the 2008 year. Read SEC document |
| April 25, 2008 Filed Apr 29, 2008 20:01 UTC | Merck & Co., Inc. SGP · Entity 2807 | Exercise / conversionDeferred Stock Unit Award · Derivative | 17,500 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0000310158-08-000020 · koh654.xml · derivative · entry 4 KOHAN RAUL E · CIK 0001238302 · President, Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,500 Underlying: Common Shares · 17,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Not Applicable. F6 · price: Not Applicable. F4 · derivative.exercise_date: Not Applicable. F5 · derivative.expiration_date: Not Applicable. Read SEC document |
| April 25, 2008 Filed Apr 29, 2008 20:01 UTC | Merck & Co., Inc. SGP · Entity 2807 | Tax withholdingCommon Shares | 6,362 | $18.64 | $118,587.68 |
DisclosureSEC source: 0000310158-08-000020 · koh654.xml · nonDerivative · entry 2 KOHAN RAUL E · CIK 0001238302 · President, Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,310.91 Read SEC document |
| April 25, 2008 Filed Apr 29, 2008 20:01 UTC | Merck & Co., Inc. SGP · Entity 2807 | Exercise / conversionCommon Shares | 17,500 | $0.00 | $0.00 |
DisclosureSEC source: 0000310158-08-000020 · koh654.xml · nonDerivative · entry 1 KOHAN RAUL E · CIK 0001238302 · President, Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,672.91 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Not Applicable. Read SEC document |
| December 03, 2007 Filed Dec 5, 2007 15:58 UTC | Merck & Co., Inc. SGP · Entity 2807 | Exercise / conversionDeferred Stock Unit Award · Derivative | 2,720 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0000310158-07-000094 · koh644.xml · derivative · entry 4 KOHAN RAUL E · CIK 0001238302 · President, Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Shares · 2,720 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Not Applicable. F6 · price: Not Applicable. F4 · derivative.exercise_date: Not Applicable. F5 · derivative.expiration_date: Not Applicable. Read SEC document |
| December 03, 2007 Filed Dec 5, 2007 15:58 UTC | Merck & Co., Inc. SGP · Entity 2807 | Tax withholdingCommon Shares | 1,261 | $30.81 | $38,851.41 |
DisclosureSEC source: 0000310158-07-000094 · koh644.xml · nonDerivative · entry 2 KOHAN RAUL E · CIK 0001238302 · President, Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,172.91 Read SEC document |
| December 03, 2007 Filed Dec 5, 2007 15:58 UTC | Merck & Co., Inc. SGP · Entity 2807 | Exercise / conversionCommon Shares | 2,720 | $0.00 | $0.00 |
DisclosureSEC source: 0000310158-07-000094 · koh644.xml · nonDerivative · entry 1 KOHAN RAUL E · CIK 0001238302 · President, Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,433.91 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Not Applicable. Read SEC document |
| May 01, 2007 Filed May 3, 2007 14:16 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantOption (right to buy) · Derivative | 100,000 | Not disclosed Strike: $31.57 | Not disclosed |
DisclosureSEC source: 0000310158-07-000028 · koh610.xml · derivative · entry 1 KOHAN RAUL E · CIK 0001238302 · President, Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Shares · 100,000 shares Expires 2014-04-30 F2 · price: Not Applicable. F1 · derivative.exercise_date: Granted under the Schering-Plough Corporation 2006 Stock Incentive Plan and exercisable in one-third increments on May 1 of 2008, 2009 and 2010. The vesting of 20,000 option shares is subject to Schering-Plough's satisfaction of certain performance criteria for the 2007 year. Read SEC document |
| December 01, 2006 Filed Dec 5, 2006 01:22 UTC | Merck & Co., Inc. SGP · Entity 2807 | Exercise / conversionDeferred Stock Unit Award · Derivative | 17,440 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0000310158-06-000143 · koh576.xml · derivative · entry 4 KOHAN RAUL E · CIK 0001238302 · President, Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,720 Underlying: Common Shares · 17,440 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Not Applicable. F6 · price: Not Applicable. F4 · derivative.exercise_date: Not Applicable. F5 · derivative.expiration_date: Not Applicable. Read SEC document |
| December 01, 2006 Filed Dec 5, 2006 01:22 UTC | Merck & Co., Inc. SGP · Entity 2807 | Tax withholdingCommon Shares | 8,084 | $21.93 | $177,282.12 |
DisclosureSEC source: 0000310158-06-000143 · koh576.xml · nonDerivative · entry 2 KOHAN RAUL E · CIK 0001238302 · President, Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,713.91 Read SEC document |
| December 01, 2006 Filed Dec 5, 2006 01:22 UTC | Merck & Co., Inc. SGP · Entity 2807 | Exercise / conversionCommon Shares | 17,440 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000310158-06-000143 · koh576.xml · nonDerivative · entry 1 KOHAN RAUL E · CIK 0001238302 · President, Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,797.91 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Not Applicable. Read SEC document |
| November 29, 2006 Filed Nov 30, 2006 21:52 UTC | Merck & Co., Inc. SGP · Entity 2807 | Exercise / conversionOption (right to buy) · Derivative | 10,200 | Not disclosed Strike: $19.81 | Not disclosed |
DisclosureSEC source: 0000310158-06-000117 · koh583.xml · derivative · entry 4 KOHAN RAUL E · CIK 0001238302 · President, Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 10,200 shares Expires 2007-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Not Applicable. F2 · derivative.exercise_date: This option, covering 20,400 shares, became exercisable on February 25, 1998. Read SEC document |
| November 29, 2006 Filed Nov 30, 2006 21:52 UTC | Merck & Co., Inc. SGP · Entity 2807 | SaleCommon Shares | 10,200 | $22.20 | $226,440.00 |
DisclosureSEC source: 0000310158-06-000117 · koh583.xml · nonDerivative · entry 2 KOHAN RAUL E · CIK 0001238302 · President, Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,357.91 Read SEC document |
| November 29, 2006 Filed Nov 30, 2006 21:52 UTC | Merck & Co., Inc. SGP · Entity 2807 | Exercise / conversionCommon Shares | 10,200 | $19.81 | $202,062.00 |
DisclosureSEC source: 0000310158-06-000117 · koh583.xml · nonDerivative · entry 1 KOHAN RAUL E · CIK 0001238302 · President, Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,557.91 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 16, 2006 Filed Nov 20, 2006 20:16 UTC | Merck & Co., Inc. SGP · Entity 2807 | Exercise / conversionOption (right to buy) · Derivative | 10,200 | Not disclosed Strike: $19.81 | Not disclosed |
DisclosureSEC source: 0000310158-06-000115 · koh575.xml · derivative · entry 4 KOHAN RAUL E · CIK 0001238302 · President, Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,200 Underlying: Common Shares · 10,200 shares Expires 2007-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Not Applicable. F2 · derivative.exercise_date: This option, covering 20,400 shares, became exercisable on February 25, 1998. Read SEC document |
| November 16, 2006 Filed Nov 20, 2006 20:16 UTC | Merck & Co., Inc. SGP · Entity 2807 | SaleCommon Shares | 10,200 | $22.00 | $224,400.00 |
DisclosureSEC source: 0000310158-06-000115 · koh575.xml · nonDerivative · entry 2 KOHAN RAUL E · CIK 0001238302 · President, Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,357.91 Read SEC document |
| November 16, 2006 Filed Nov 20, 2006 20:16 UTC | Merck & Co., Inc. SGP · Entity 2807 | Exercise / conversionCommon Shares | 10,200 | $19.81 | $202,062.00 |
DisclosureSEC source: 0000310158-06-000115 · koh575.xml · nonDerivative · entry 1 KOHAN RAUL E · CIK 0001238302 · President, Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,557.91 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 19, 2006 Filed May 23, 2006 20:53 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantOption (right to buy) · Derivative | 100,000 | Not disclosed Strike: $19.23 | Not disclosed |
DisclosureSEC source: 0000310158-06-000071 · koh536.xml · derivative · entry 2 KOHAN RAUL E · CIK 0001238302 · President, Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Shares · 100,000 shares Expires 2013-05-18 F6 · price: Not Applicable. F5 · derivative.exercise_date: Granted under Schering-Plough Corporation 2006 Stock Incentive Plan and exerciseable in one-third increments on April 1 of 2007, 2008 and 2009. The vesting of 20,000 option shares is subject to Schering-Plough's satisfaction of certain performance criteria for the year 2006. Read SEC document |
| May 19, 2006 Filed May 23, 2006 20:53 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantDeferred Stock Unit Award · Derivative | 17,500 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0000310158-06-000071 · koh536.xml · derivative · entry 1 KOHAN RAUL E · CIK 0001238302 · President, Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,160 Underlying: Common Shares · 17,500 shares Expires not disclosed F1 · derivative.exercise_price: Not Applicable. F4 · price: Not Applicable. F2 · derivative.exercise_date: Granted under Schering-Plough Corporation 2006 Stock Incentive Plan. All of the shares become deliverable on April 1, 2009 subject to Schering-Plough's satisfaction of certain performance criteria for the year 2006. F3 · derivative.expiration_date: Not Applicable. Read SEC document |
| December 14, 2005 Filed Dec 16, 2005 16:17 UTC | Merck & Co., Inc. SGP · Entity 2807 | Exercise / conversionOption (right to buy) · Derivative | 9,800 | $0.00 Strike: $13.97 | $0.00 |
DisclosureSEC source: 0000310158-05-000103 · koh518.xml · derivative · entry 4 KOHAN RAUL E · CIK 0001238302 · President, Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 9,800 shares Expires 2006-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These options are currently exercisable. Read SEC document |
| December 14, 2005 Filed Dec 16, 2005 16:17 UTC | Merck & Co., Inc. SGP · Entity 2807 | SaleCommon Shares | 9,800 | $19.82 | $194,236.00 |
DisclosureSEC source: 0000310158-05-000103 · koh518.xml · nonDerivative · entry 2 KOHAN RAUL E · CIK 0001238302 · President, Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,357.91 Read SEC document |
| December 14, 2005 Filed Dec 16, 2005 16:17 UTC | Merck & Co., Inc. SGP · Entity 2807 | Exercise / conversionCommon Shares | 9,800 | $13.97 | $136,906.00 |
DisclosureSEC source: 0000310158-05-000103 · koh518.xml · nonDerivative · entry 1 KOHAN RAUL E · CIK 0001238302 · President, Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,157.91 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 01, 2005 Filed Dec 2, 2005 23:00 UTC | Merck & Co., Inc. SGP · Entity 2807 | Exercise / conversionDeferred Stock Unit Award · Derivative | 8,160 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000310158-05-000091 · koh501.xml · derivative · entry 4 KOHAN RAUL E · CIK 0001238302 · President, Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,660 Underlying: Common Shares · 8,160 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Not Applicable. F6 · price: Not Applicable. F4 · derivative.exercise_date: Not Applicable. F5 · derivative.expiration_date: Not Applicable. Read SEC document |
| December 01, 2005 Filed Dec 2, 2005 23:00 UTC | Merck & Co., Inc. SGP · Entity 2807 | Tax withholdingCommon Shares | 3,783 | $19.05 | $72,066.15 |
DisclosureSEC source: 0000310158-05-000091 · koh501.xml · nonDerivative · entry 2 KOHAN RAUL E · CIK 0001238302 · President, Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,357.91 Read SEC document |
| December 01, 2005 Filed Dec 2, 2005 23:00 UTC | Merck & Co., Inc. SGP · Entity 2807 | Exercise / conversionCommon Shares | 8,160 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000310158-05-000091 · koh501.xml · nonDerivative · entry 1 KOHAN RAUL E · CIK 0001238302 · President, Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,140.91 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Not Applicable. Read SEC document |
| July 22, 2005 Filed Jul 26, 2005 15:55 UTC | Merck & Co., Inc. SGP · Entity 2807 | Exercise / conversionOption (right to buy) · Derivative | 100,000 | $0.00 Strike: $12.91 | $0.00 |
DisclosureSEC source: 0000310158-05-000066 · koh491.xml · derivative · entry 5 KOHAN RAUL E · CIK 0001238302 · President, Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 100,000 shares Expires 2005-09-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option, covering 200,000 shares, became exercisable in 20% increments on each of September 26, 2000, 2001, 2002, 2003 and 2004. Read SEC document |
| July 22, 2005 Filed Jul 26, 2005 15:55 UTC | Merck & Co., Inc. SGP · Entity 2807 | SaleCommon Shares | 50,000 | $20.41 | $1,020,500.00 |
DisclosureSEC source: 0000310158-05-000066 · koh491.xml · nonDerivative · entry 3 KOHAN RAUL E · CIK 0001238302 · President, Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,980.91 Read SEC document |
| July 22, 2005 Filed Jul 26, 2005 15:55 UTC | Merck & Co., Inc. SGP · Entity 2807 | SaleCommon Shares | 50,000 | $20.44 | $1,022,000.00 |
DisclosureSEC source: 0000310158-05-000066 · koh491.xml · nonDerivative · entry 2 KOHAN RAUL E · CIK 0001238302 · President, Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,980.91 Read SEC document |
| July 22, 2005 Filed Jul 26, 2005 15:55 UTC | Merck & Co., Inc. SGP · Entity 2807 | Exercise / conversionCommon Shares | 100,000 | $12.91 | $1,291,000.00 |
DisclosureSEC source: 0000310158-05-000066 · koh491.xml · nonDerivative · entry 1 KOHAN RAUL E · CIK 0001238302 · President, Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,980.91 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 17, 2005 Filed May 19, 2005 21:11 UTC | Merck & Co., Inc. SGP · Entity 2807 | Exercise / conversionOption (right to buy) · Derivative | 100,000 | $0.00 Strike: $12.91 | $0.00 |
DisclosureSEC source: 0000310158-05-000053 · koh485.xml · derivative · entry 4 KOHAN RAUL E · CIK 0001238302 · President, Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Shares · 100,000 shares Expires 2005-09-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option, covering 200,000 shares, became exercisable in 20% increments on each of September 26, 2000, 2001, 2002, 2003 and 2004. Read SEC document |
| May 17, 2005 Filed May 19, 2005 21:11 UTC | Merck & Co., Inc. SGP · Entity 2807 | SaleCommon Shares | 100,000 | $20.25 | $2,025,000.00 |
DisclosureSEC source: 0000310158-05-000053 · koh485.xml · nonDerivative · entry 2 KOHAN RAUL E · CIK 0001238302 · President, Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,980.91 Read SEC document |
| May 17, 2005 Filed May 19, 2005 21:11 UTC | Merck & Co., Inc. SGP · Entity 2807 | Exercise / conversionCommon Shares | 100,000 | $12.91 | $1,291,000.00 |
DisclosureSEC source: 0000310158-05-000053 · koh485.xml · nonDerivative · entry 1 KOHAN RAUL E · CIK 0001238302 · President, Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,980.91 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 25, 2005 Filed Apr 27, 2005 19:50 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantOption (right to buy) · Derivative | 100,000 | Not disclosed Strike: $20.70 | Not disclosed |
DisclosureSEC source: 0000310158-05-000022 · koh477.xml · derivative · entry 2 KOHAN RAUL E · CIK 0001238302 · President, Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Shares · 100,000 shares Expires 2015-04-24 F6 · price: Not Applicable. F5 · derivative.exercise_date: Granted under the Schering-Plough Corporation 2002 Stock Incentive Plan, exercisable in one-third increments on April 26 of each 2006, 2007 and 2008, subject to Schering-Plough's satisfaction of certain performance criteria for the year 2005 with respect to 20,000 option shares. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.